Holderness Investments Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.98M Buy
33,090
+808
+3% +$93.3K 0.8% 28
2025
Q4
$3.4M Sell
32,282
-622
-2% -$58.4K 0.69% 34
2025
Q3
$2.76M Sell
32,904
-2,367
-7% -$195K 0.56% 42
2025
Q2
$2.79M Sell
35,271
-9,746
-22% -$775K 0.6% 43
2025
Q1
$4.04M Sell
45,017
-213
-0.5% -$19.9K 0.94% 25
2024
Q4
$4.5M Sell
45,230
-1,754
-4% -$181K 0.99% 21
2024
Q3
$5.34M Buy
46,984
+24
+0.1% +$2.85K 1.17% 18
2024
Q2
$5.81M Sell
46,960
-191
-0.4% -$24.6K 1.37% 11
2024
Q1
$6.22M Sell
47,151
-73
-0.2% -$9K 1.52% 8
2023
Q4
$5.15M Buy
47,224
+11,022
+30% +$1.14M 1.41% 9
2023
Q3
$3.73M Sell
36,202
-282
-0.8% -$30.4K 1.45% 11
2023
Q2
$4.21M Buy
36,484
+1,368
+4% +$155K 1.56% 10
2023
Q1
$3.74M Buy
35,116
+586
+2% +$63.3K 1.49% 15
2022
Q4
$3.83M Sell
34,530
-469
-1% -$47.9K 1.65% 12
2022
Q3
$3.01M Sell
34,999
-389
-1% -$34.7K 1.37% 17
2022
Q2
$3.23M Sell
35,388
-668
-2% -$59.2K 1.35% 17
2022
Q1
$2.96M Buy
36,056
+491
+1% +$38.7K 0.99% 21
2021
Q4
$2.73M Buy
35,565
+772
+2% +$61.5K 0.81% 32
2021
Q3
$2.61M Buy
34,793
+15
+0% +$1.14K 0.86% 31
2021
Q2
$2.71M Sell
34,778
-520
-1% -$38.7K 0.89% 28
2021
Q1
$2.6M Sell
35,298
-208
-0.6% -$15.3K 0.93% 25
2020
Q4
$2.77M Sell
35,506
-828
-2% -$63.3K 1.08% 24
2020
Q3
$2.88M Buy
36,334
+4,733
+15% +$371K 1.19% 21
2020
Q2
$2.33M Buy
31,601
+2,113
+7% +$159K 1.04% 25
2020
Q1
$2.17M Sell
29,488
-1,213
-4% -$95.3K 1.22% 22
2019
Q4
$2.66M Sell
30,701
-522
-2% -$42.9K 1.14% 22
2019
Q3
$2.51M Sell
31,223
-41
-0.1% -$3.29K 1.17% 21
2019
Q2
$2.5M Buy
31,264
+1,128
+4% +$86.4K 1.13% 21
2019
Q1
$2.39M Sell
30,136
-44
-0.1% -$3.29K 1.15% 23
2018
Q4
$2.2M Buy
30,180
+405
+1% +$28.6K 1.2% 21
2018
Q3
$2.02M Buy
29,775
+884
+3% +$56.3K 0.91% 26
2018
Q2
$1.67M Sell
28,891
-30
-0.1% -$1.69K 0.81% 31
2018
Q1
$1.5M Buy
28,921
+2,067
+8% +$112K 0.74% 37
2017
Q4
$1.44M Buy
26,854
+152
+0.6% +$8.43K 0.71% 42
2017
Q3
$1.63M Sell
26,702
-241
-0.9% -$14.6K 0.85% 31
2017
Q2
$1.65M Sell
26,943
-129
-0.5% -$7.85K 0.87% 30
2017
Q1
$1.64M Buy
27,072
+5,099
+23% +$309K 0.83% 33
2016
Q4
$1.23M Buy
21,973
+377
+2% +$22.1K 1.09% 32
2016
Q3
$1.29M Hold
21,596
1.29% 23
2016
Q2
$1.19M Sell
21,596
-613
-3% -$32.6K 1.2% 29
2016
Q1
$1.12M Buy
22,209
+2,255
+11% +$110K 1.07% 31
2015
Q4
$1.01M Sell
19,954
-286
-1% -$14.4K 1% 36
2015
Q3
$954K Buy
20,240
+554
+3% +$29.4K 1% 36
2015
Q2
$1.07M Buy
19,686
+1,834
+10% +$103K 1.09% 34
2015
Q1
$979K Buy
17,852
+1,993
+13% +$113K 0.99% 39
2014
Q4
$859K Buy
+15,859
New +$884K 0.88% 42

Other funds holding MRK

Holderness Investments Company's MRK Position: Q1 2026 in Review

Holderness Investments Company increased its Merck (MRK) stake by 2.5% in Q1 2026, buying an estimated $93.3K and bringing the position to 33,090 shares worth $3.98M. The position accounts for 0.8% of the portfolio, ranked #28.

Holderness Investments Company first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.22M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Holderness Investments Company held 33,090 shares of Merck worth $3.98M as of Q1 2026.
  • Holderness Investments Company bought 808 Merck shares in Q1 2026, an estimated $93.3K.
  • Merck made up 0.8% of Holderness Investments Company's portfolio in Q1 2026, its #28 holding.
  • Holderness Investments Company first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
  • Holderness Investments Company's Merck position peaked at $6.22M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.